Otonomy, Inc.

ACTIVE

4796 Executive Dr, San Diego, California, United Stateswww.otonomy.comPrivate51–100 employeesEstablished: 2008-01-01

Also known as:

otonomy

Clinical Trials

11 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2008

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

45.5%

Phase 3

30.3%

Phase 2

24.2%

Trial Status Distribution

Active, not recruiting

33.3%

Completed

51.5%

Terminated

15.2%

Clinical Trials

Trials sponsored by this organization (33)

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Phase 2

Completed

interventional

Mar 2021153 participants

A study to see of local application (in the ear) of dexamethasone (a corticosteroid) to people with Meniere's disease could help with their symptoms and if it is safe to use.

Phase 1

Active, not recruiting

Dec 2020180 participants

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Phase 1

Completed

interventional

Oct 2019110 participants

OTO-313 in Subjects With Subjective Tinnitus

Phase 1

Completed

interventional

Apr 201943 participants

A study to see of local application (in the ear) of dexamethasone (a corticosteroid) to people with Meniere's disease could help with their symptoms and if it is safe to use.

Phase 1

Active, not recruiting

Feb 2019180 participants

A study to see of local application (in the ear) of dexamethasone (a corticosteroid) to people with Meniere's disease could help with their symptoms and if it is safe to use.

Phase 1

Active, not recruiting

Jan 2019160 participants

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Phase 3

Completed

interventional

Aug 2018148 participants

A study to see of local application (in the ear) of dexamethasone (a corticosteroid) to people with Meniere's disease could help with their symptoms and if it is safe to use.

Phase 1

Active, not recruiting

Jul 2018180 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

Back to Organizations